TECHNOLOGY LICENSING - PLATFORM AGREEMENTTechnology Licensing Agreement • June 21st, 2022 • Virtuoso Surgical, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJune 21st, 2022 Company IndustryThis Platform Agreement (“Platform Agreement” or “Agreement”) is entered into as of the date noted below (the “Effective Date”) between Capital2Market, LLC, a Virginia Limited Liability Company (“Company” or “us”), and the customer listed above (“Customer” or “you”). This Platform Agreement includes and incorporates this, the attached Software as a Service Terms and Conditions (“SaaS Terms and Conditions”), and amendments hereto, and supersedes all previous understandings and agreements between the parties, whether oral or written. There shall be no force or effect to any different terms of any related order form or similar form even if signed by the parties after the date hereof. By signing this Platform Agreement as indicated below, you agree to the terms and conditions of this Platform Agreement and the SaaS Terms and Conditions. In addition, you attest to the Company that you are authorized to agree to this Platform Agreement and any other agreements necessary in order to process s
EXCLUSIVE PLACEMENT AGENCY AGREEMENTExclusive Placement Agency Agreement • June 21st, 2022 • Virtuoso Surgical, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 21st, 2022 Company Industry JurisdictionThis Placement Agency Agreement (this “Agreement”) is made as of May 16th, 2022, between Virtuoso Surgical, Inc., a Tennessee corporation (the “Company”), and C2M Securities, LLC, a Virginia limited liability company (the “Placement Agent”). The Placement Agent and the Company agree:
FORM OF SUBSCRIPTION AGREEMENT FOR COMMON STOCK OF VIRTUOSO SURGICAL, INC.Subscription Agreement • June 21st, 2022 • Virtuoso Surgical, Inc. • Surgical & medical instruments & apparatus • Tennessee
Contract Type FiledJune 21st, 2022 Company Industry JurisdictionThis subscription agreement (the “Subscription Agreement”) is being executed and delivered by the undersigned prospective investor (the “Prospective Investor”) in connection with the public offering (the “Offering”) of up to 333,333 shares of Common Stock, no par value (the “Shares”), of Virtuoso Surgical, Inc., a Tennessee corporation (the “Company”).